1 Relevant Concepts of Mecapegfilgrastim 1.1 Indications of Mecapegfilgrastim 1.2 Development of China’s Mecapegfilgrastim Market 1.3 Governmental Approval of Mecapegfilgrastim in China 1.4 The Impact of COVID-19 on China’s Mecapegfilgrastim Market 2 Sales of Mecapegfilgrastim in China, 2016-2020 2.1 Sales Value 2.1.1 Sales Value in China 2.1.2 Sales Value in China by Region 2.2 Sales Volume 2.2.1 Sales Volume in China 2.2.2 Sales Volume in China by Region 2.3 Sales of Mecapegfilgrastim in China by Dosage Form, 2016-2020 2.3.1 Injection 2.3.2 Other Dosage Forms 3 Analysis of Major Mecapegfilgrastim Manufacturers in China, 2020 3.1 Analysis of Market Share 3.1.1 Market Share of Manufacturers by Sales Value 3.1.2 Market Share of Manufacturers by Sales Volume 3.2 Jiangsu Hengrui Medicine Co., Ltd. 3.2.1 Company Profile 3.2.2 Sales of Mecapegfilgrastim in China 4 Selling Prices of Mecapegfilgrastim of Different Companies in China, 2020-2021 4.1 Jiangsu Hengrui Medicine Co., Ltd. (Aiduo®) 4.2 Other Companies 5 Prospects of China’s Mecapegfilgrastim Market, 2021-2025 5.1 Influencing Factors for the Market Development 5.1.1 The Impact of COVID-19 on the Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information of Mecapegfilgrastim in China Chart Sales Value of Mecapegfilgrastim in China, 2016-2020 Chart Sales Volume of Mecapegfilgrastim in China, 2016-2020 Chart Sales Value of Mecapegfilgrastim Injection in China, 2016-2020 Chart Sales Value and Volume of Mecapegfilgrastim (of Jiangsu Hengrui Medicine Co., Ltd.) in China, 2016-2020 Chart Selling Price of Aiduo (Mecapegfilgrastim of Jiangsu Hengrui Medicine Co., Ltd.) in China, 2020 Chart Forecast on Sales Value of Mecapegfilgrastim in China, 2021-2025 Chart Forecast on Sales Volume of Mecapegfilgrastim in China, 2021-2025